Skip to main content
Erschienen in: Surgical Endoscopy 9/2015

01.09.2015

Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases

verfasst von: Roberto Montalti, Federico Tomassini, Stéphanie Laurent, Peter Smeets, Marc De Man, Karen Geboes, Louis J. Libbrecht, Roberto I. Troisi

Erschienen in: Surgical Endoscopy | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The relationship between the width of surgical margins and local and distant recurrence of colorectal liver metastases (CRLM) remain controversial. We analyzed the impact of surgical margins in laparoscopic liver resections (LLR) for CRLM, using the parenchymal-sparing approach on overall (OS) and recurrence-free survival (RFS).

Methods

From January 2005 to October 2012, 114 first LLR for CRLM were performed and retrospectively analyzed. The ultrasonic aspirator was used for parenchyma division. R1 margins were defined when the tissue width was <1 mm.

Results

After a mean follow-up of 30.9 ± 1.71 months, OS was 97.1–73.9–58.9 % and the RFS 64.2–35.2–31 % at 1–3–5 years, respectively. The major resection rate was 7 %. The median margin width was 3 (0–40) mm, and R1 resection was recorded in 14 (12.3 %) cases. Twenty-two patients (33.3 %) with hepatic recurrence underwent a repeat hepatectomy. R1 margins were significantly related to lower RFS survival (p = 0.038) but did not affect OS. Multivariate analysis showed that lesions located in postero-superior segments (HR = 2.4, 95 % CI 1.24–4.61, p = 0.009) as well as blood loss (HR = 3.2, 95 % CI 1.23–7.99, p = 0.012) were independent risk factors for tumor recurrence. The carcinoembryonic antigen level >10 mcg/L affected OS (HR = 4.2 95 % CI 2.02–16.9, p = 0.001), and the resection of more than two tumors was significantly associated with R1 margins (HR = 9.32, 95 % CI 1.14–32.5, p = 0.037).

Discussion

Laparoscopic parenchymal-sparing surgery of CRLM does not compromise the oncological outcome, allowing a higher percentage of repeat hepatectomy. R1 margins are a risk factor for tumor recurrence but not for overall survival. The presence of multiple lesions is the only independent risk factor of R1 margins and also the major disadvantage of this technique.
Literatur
1.
Zurück zum Zitat Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D’Angelica M (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246:295–300PubMedCentralCrossRefPubMed Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D’Angelica M (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246:295–300PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318 discussion 318-321PubMedCentralCrossRefPubMed Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318 discussion 318-321PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17:1324–1329CrossRefPubMed Muratore A, Ribero D, Zimmitti G, Mellano A, Langella S, Capussotti L (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17:1324–1329CrossRefPubMed
4.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722 discussion 722-714PubMedCentralCrossRefPubMed Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722 discussion 722-714PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X (2012) Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Ann Surg Oncol 19:2860–2868CrossRefPubMed Dexiang Z, Li R, Ye W, Haifu W, Yunshi Z, Qinghai Y, Shenyong Z, Bo X, Li L, Xiangou P, Haohao L, Lechi Y, Tianshu L, Jia F, Xinyu Q, Jianmin X (2012) Outcome of patients with colorectal liver metastasis: analysis of 1,613 consecutive cases. Ann Surg Oncol 19:2860–2868CrossRefPubMed
6.
Zurück zum Zitat Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G (2010) Surgical management and outcomes of colorectal cancer liver metastases. The British journal of surgery 97:1110–1118CrossRefPubMed Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G (2010) Surgical management and outcomes of colorectal cancer liver metastases. The British journal of surgery 97:1110–1118CrossRefPubMed
7.
Zurück zum Zitat Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crino L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G, Gruppo Oncologico Nord O (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670–1676CrossRefPubMed Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crino L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G, Gruppo Oncologico Nord O (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25:1670–1676CrossRefPubMed
8.
Zurück zum Zitat Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414CrossRefPubMed Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405–414CrossRefPubMed
9.
Zurück zum Zitat Spolverato G, Ejaz A, Azad N, Pawlik TM (2013) Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol 5:207–221PubMedCentralCrossRefPubMed Spolverato G, Ejaz A, Azad N, Pawlik TM (2013) Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol 5:207–221PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644–657 discussion 657-648PubMedCentralCrossRefPubMed Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644–657 discussion 657-648PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M (2006) Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93:1001–1006CrossRefPubMed Capussotti L, Muratore A, Mulas MM, Massucco P, Aglietta M (2006) Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93:1001–1006CrossRefPubMed
12.
Zurück zum Zitat Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S (2007) Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205:676–683CrossRefPubMed Shah SA, Bromberg R, Coates A, Rempel E, Simunovic M, Gallinger S (2007) Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg 205:676–683CrossRefPubMed
13.
Zurück zum Zitat Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247:109–117CrossRefPubMed Gold JS, Are C, Kornprat P, Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Blumgart LH, D’Angelica M (2008) Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients. Ann Surg 247:109–117CrossRefPubMed
14.
Zurück zum Zitat Vigano L, Ferrero A, Sgotto E, Polastri R, Muratore A, Capussotti L (2005) Parenchyma sparing: evolution of the resective surgical approach of hepatic metastasis from the colorectum. I supplementi di Tumori 4:S35PubMed Vigano L, Ferrero A, Sgotto E, Polastri R, Muratore A, Capussotti L (2005) Parenchyma sparing: evolution of the resective surgical approach of hepatic metastasis from the colorectum. I supplementi di Tumori 4:S35PubMed
15.
Zurück zum Zitat Postriganova N, Kazaryan AM, Røsok BI, Fretland AA, Barkhatov L, Edwin B (2014) Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence? HPB 16(9):822–829 Postriganova N, Kazaryan AM, Røsok BI, Fretland AA, Barkhatov L, Edwin B (2014) Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence? HPB 16(9):822–829
16.
Zurück zum Zitat Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI (2014) Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case–control matched-pairs analysis. Eur J Surg Oncol 40(5):536–544CrossRefPubMed Montalti R, Berardi G, Laurent S, Sebastiani S, Ferdinande L, Libbrecht LJ, Smeets P, Brescia A, Rogiers X, de Hemptinne B, Geboes K, Troisi RI (2014) Laparoscopic liver resection compared to open approach in patients with colorectal liver metastases improves further resectability: Oncological outcomes of a case–control matched-pairs analysis. Eur J Surg Oncol 40(5):536–544CrossRefPubMed
17.
Zurück zum Zitat Nguyen KT, Gamblin TC, Geller DA (2009) World review of laparoscopic liver resection: 2,804 patients. Ann Surg 250:831–841CrossRefPubMed Nguyen KT, Gamblin TC, Geller DA (2009) World review of laparoscopic liver resection: 2,804 patients. Ann Surg 250:831–841CrossRefPubMed
19.
Zurück zum Zitat Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227:566–571PubMedCentralCrossRefPubMed Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227:566–571PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727–731CrossRefPubMed Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727–731CrossRefPubMed
21.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262CrossRefPubMed Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77:1254–1262CrossRefPubMed
22.
Zurück zum Zitat Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84:1077–1080CrossRefPubMed Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84:1077–1080CrossRefPubMed
23.
Zurück zum Zitat Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69:88–93CrossRefPubMed Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69:88–93CrossRefPubMed
24.
Zurück zum Zitat Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C (2011) Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 254:234–242CrossRefPubMed Dhir M, Lyden ER, Wang A, Smith LM, Ullrich F, Are C (2011) Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 254:234–242CrossRefPubMed
25.
Zurück zum Zitat Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12:165–192 xiCrossRefPubMed Altendorf-Hofmann A, Scheele J (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12:165–192 xiCrossRefPubMed
26.
Zurück zum Zitat Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, Codina-Barreras A, Mojal S (2007) Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 18:1190–1195CrossRefPubMed Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, Codina-Barreras A, Mojal S (2007) Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections. Ann Oncol 18:1190–1195CrossRefPubMed
27.
Zurück zum Zitat Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 143:384–393CrossRefPubMed Nuzzo G, Giuliante F, Ardito F, Vellone M, Giovannini I, Federico B, Vecchio FM (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 143:384–393CrossRefPubMed
28.
Zurück zum Zitat Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138CrossRefPubMed Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138CrossRefPubMed
29.
Zurück zum Zitat de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626–637PubMed de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R (2008) R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 248:626–637PubMed
30.
Zurück zum Zitat Strasberg SM (1997) Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 184:413–434PubMed Strasberg SM (1997) Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel. J Am Coll Surg 184:413–434PubMed
31.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralCrossRefPubMed Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Schultz NA, Larsen PN, Klarskov B, Plum LM, Frederiksen HJ, Christensen BM, Kehlet H, Hillingso JG (2013) Evaluation of a fast-track programme for patients undergoing liver resection. Br J Surg 100:138–143CrossRefPubMed Schultz NA, Larsen PN, Klarskov B, Plum LM, Frederiksen HJ, Christensen BM, Kehlet H, Hillingso JG (2013) Evaluation of a fast-track programme for patients undergoing liver resection. Br J Surg 100:138–143CrossRefPubMed
33.
Zurück zum Zitat Troisi RI, Montalti R, Van Limmen JG, Cavaniglia D, Reyntjens K, Rogiers X, De Hemptinne B (2013) Risk factors and management of conversions to an open approach in laparoscopic liver resection: analysis of 265 consecutive cases. HPB 16(1):75–82PubMedCentralCrossRefPubMed Troisi RI, Montalti R, Van Limmen JG, Cavaniglia D, Reyntjens K, Rogiers X, De Hemptinne B (2013) Risk factors and management of conversions to an open approach in laparoscopic liver resection: analysis of 265 consecutive cases. HPB 16(1):75–82PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335PubMed Hanley JA (1989) Receiver operating characteristic (ROC) methodology: the state of the art. Crit Rev Diagn Imaging 29:307–335PubMed
35.
Zurück zum Zitat Lam VW, Laurence JM, Pang T, Johnston E, Hollands MJ, Pleass HC, Richardson AJ (2014) A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB 16:101–108PubMedCentralCrossRefPubMed Lam VW, Laurence JM, Pang T, Johnston E, Hollands MJ, Pleass HC, Richardson AJ (2014) A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB 16:101–108PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat von Heesen M, Schuld J, Sperling J, Grunhage F, Lammert F, Richter S, Schilling MK, Kollmar O (2012) Parenchyma-preserving hepatic resection for colorectal liver metastases. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 397:383–395CrossRef von Heesen M, Schuld J, Sperling J, Grunhage F, Lammert F, Richter S, Schilling MK, Kollmar O (2012) Parenchyma-preserving hepatic resection for colorectal liver metastases. Langenbeck’s Arch Surg/Deutsche Gesellschaft fur Chirurgie 397:383–395CrossRef
37.
Zurück zum Zitat Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN (2013) Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 257:1079–1088PubMedCentralCrossRefPubMed Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN (2013) Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 257:1079–1088PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Hamady ZZ, Lodge JP, Welsh FK, Toogood GJ, White A, John T, Rees M (2013) One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg 259(3):543–548CrossRef Hamady ZZ, Lodge JP, Welsh FK, Toogood GJ, White A, John T, Rees M (2013) One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg 259(3):543–548CrossRef
39.
Zurück zum Zitat Konopke R, Kersting S, Makowiec F, Gassmann P, Kuhlisch E, Senninger N, Hopt U, Saeger HD (2008) Resection of colorectal liver metastases: is a resection margin of 3 mm enough? a multicenter analysis of the GAST Study Group. World J Surg 32:2047–2056CrossRefPubMed Konopke R, Kersting S, Makowiec F, Gassmann P, Kuhlisch E, Senninger N, Hopt U, Saeger HD (2008) Resection of colorectal liver metastases: is a resection margin of 3 mm enough? a multicenter analysis of the GAST Study Group. World J Surg 32:2047–2056CrossRefPubMed
40.
Zurück zum Zitat Vandeweyer D, Neo EL, Chen JW, Maddern GJ, Wilson TG, Padbury RT (2009) Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB 11:499–504PubMedCentralCrossRefPubMed Vandeweyer D, Neo EL, Chen JW, Maddern GJ, Wilson TG, Padbury RT (2009) Influence of resection margin on survival in hepatic resections for colorectal liver metastases. HPB 11:499–504PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Holdhoff M, Schmidt K, Diehl F, Aggrawal N, Angenendt P, Romans K, Edelstein DL, Torbenson M, Kinzler KW, Vogelstein B, Choti MA, Diaz LA Jr (2011) Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res 17:3551–3557PubMedCentralCrossRefPubMed Holdhoff M, Schmidt K, Diehl F, Aggrawal N, Angenendt P, Romans K, Edelstein DL, Torbenson M, Kinzler KW, Vogelstein B, Choti MA, Diaz LA Jr (2011) Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res 17:3551–3557PubMedCentralCrossRefPubMed
42.
Zurück zum Zitat Sh J, Muirhead W, Zaitoun AM, Cameron IC, Lobo DN (2012) Comparison of liver parenchymal ablation and tissue necrosis in a cadaveric bovine model using the Harmonic Scalpel, the LigaSure, the Cavitron Ultrasonic Surgical Aspirator and the Aquamantys devices. HPB 14:828–832CrossRef Sh J, Muirhead W, Zaitoun AM, Cameron IC, Lobo DN (2012) Comparison of liver parenchymal ablation and tissue necrosis in a cadaveric bovine model using the Harmonic Scalpel, the LigaSure, the Cavitron Ultrasonic Surgical Aspirator and the Aquamantys devices. HPB 14:828–832CrossRef
43.
Zurück zum Zitat Ayez N, Lalmahomed ZS, Eggermont AM, Ijzermans JN, de Jonge J, van Montfort K, Verhoef C (2012) Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol 19:1618–1627PubMedCentralCrossRefPubMed Ayez N, Lalmahomed ZS, Eggermont AM, Ijzermans JN, de Jonge J, van Montfort K, Verhoef C (2012) Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol 19:1618–1627PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Aggarwal C, Meropol NJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Cohen SJ (2013) Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol 24:420–428CrossRefPubMed Aggarwal C, Meropol NJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC, Cohen SJ (2013) Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann Oncol 24:420–428CrossRefPubMed
45.
Zurück zum Zitat Edwin B, Nordin A, Kazaryan AM (2011) Laparoscopic liver surgery: new frontiers. Scand J Surg 100:54–65PubMed Edwin B, Nordin A, Kazaryan AM (2011) Laparoscopic liver surgery: new frontiers. Scand J Surg 100:54–65PubMed
46.
Zurück zum Zitat Pawlik TM, Vauthey JN (2008) Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome. Ann Surg Oncol 15:677–679PubMedCentralCrossRefPubMed Pawlik TM, Vauthey JN (2008) Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not millimeters defines outcome. Ann Surg Oncol 15:677–679PubMedCentralCrossRefPubMed
Metadaten
Titel
Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases
verfasst von
Roberto Montalti
Federico Tomassini
Stéphanie Laurent
Peter Smeets
Marc De Man
Karen Geboes
Louis J. Libbrecht
Roberto I. Troisi
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 9/2015
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-014-3999-3

Weitere Artikel der Ausgabe 9/2015

Surgical Endoscopy 9/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.